Asymchem Laboratories (Tianjin) Co., Ltd. Share Price OTC Markets
Stocks
ASLT.Y
US04651E1038
Pharmaceuticals
OTC Markets Traded
| Market Cap | 40.3B 5.96B 5.14B 4.73B 4.45B 8.37B 563B 8.44B 56.05B 21.82B 276B 22.38B 21.9B 956B | P/E 2026 * |
29.6x | P/E 2027 * | 24.5x |
|---|---|---|---|---|---|
| Enterprise Value | 35.18B 5.21B 4.49B 4.13B 3.89B 7.3B 491B 7.36B 48.93B 19.05B 241B 19.54B 19.12B 834B | EV / Sales 2026 * |
4.37x | EV / Sales 2027 * | 3.76x |
| Free-Float |
61.07% | Yield 2026 * |
1.28% | Yield 2027 * | 1.54% |
| Manager | Title | Age | Since |
|---|---|---|---|
Rui Yang
CEO | Chief Executive Officer | 49 | 18/01/2022 |
Hao Hong
CEO | Chief Executive Officer | 70 | 06/10/1998 |
Da Zhang
DFI | Director of Finance/CFO | 45 | 06/08/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Hao Hong
CHM | Chairman | 70 | 06/10/1998 |
Rui Yang
BRD | Director/Board Member | 49 | 17/07/2011 |
Xin Yi Hou
BRD | Director/Board Member | 66 | 28/02/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 5.96B | |
| -0.94% | -2.14% | +40.54% | +148.38% | 992B | |
| -0.42% | -1.80% | +53.69% | +42.60% | 564B | |
| -0.56% | -1.65% | +19.27% | +59.57% | 391B | |
| +0.06% | +0.68% | +24.66% | +16.53% | 330B | |
| -0.13% | +0.06% | +26.36% | +14.29% | 280B | |
| -0.02% | +1.65% | +26.61% | +33.32% | 279B | |
| +0.11% | +0.87% | -41.49% | -48.26% | 196B | |
| -1.78% | +1.16% | +17.79% | +48.77% | 184B | |
| -1.40% | +3.27% | +16.16% | +59.08% | 156B | |
| Average | -0.54% | +0.41% | +20.40% | +41.59% | 374.58B | |
| Weighted average by Cap. | -0.60% | -0.49% | +29.25% | +65.83% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.04B 1.19B 1.03B 944M 889M 1.67B 112B 1.68B 11.19B 4.36B 55.13B 4.47B 4.37B 191B | 9.54B 1.41B 1.22B 1.12B 1.05B 1.98B 133B 2B 13.27B 5.16B 65.37B 5.3B 5.18B 226B |
| Net income | 1.4B 208M 179M 165M 155M 292M 19.62B 294M 1.95B 761M 9.63B 780M 764M 33.31B | 1.71B 253M 219M 201M 189M 355M 23.91B 358M 2.38B 927M 11.73B 951M 930M 40.59B |
| Net Debt | -5.12B -758M -654M -601M -566M -1.06B -71.55B -1.07B -7.13B -2.77B -35.12B -2.85B -2.78B -121B | -4.46B -660M -570M -524M -493M -926M -62.31B -934M -6.21B -2.42B -30.58B -2.48B -2.43B -106B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
